Dr. Tanvi A. Dhere is an associate professor of the Division of Digestive Diseases at Emory University. She received her undergraduate degree from the Honors College at University of South Carolina in Biology. She went on to medical school at the Medical University of South Carolina in Charleston. Upon completing her MD, she left for Chicago to join the residency program at Northwestern McGaw Medical Center. She returned to the south to complete her GI fellowship at Emory. During her training, Dr. Dhere pursued research in inflammatory bowel disease and continues to focus much of her research in this area. She is particularly interested in ethnic differences as it relates to disease progression, treatment, and genetics.
Specialties
Gastroenterology
Fellowships
Emory University School of Medicine
Affiliations
Emory
Education & Training
Medical School: Medical University of South Carolina in Charleston
Residency: Northwestern McGaw Medical Center
Honors & Awards
Emory School of Medicine Dean's Teaching Award, 2021
Emory Distinguished Physician, 2021
Georgia Crohn's and Colitis Foundation Premier Physician Award, 2020
Emory Division of Digestive Diseases Educator Award, 2019
Publications
Jackson JF, Dhere T, Repaka A, Shaukat A, Sitaraman S. Crohn’s Disease in an African-American Population. Am J Med Sci Nov 2008; 336 (5): 389-392.
Lom J, Dhere T, Obideen K. Intestinal lymphangiectasia causing massive gastrointestinal bleed. J Clin Gastroenterol. Jan 2010; 44(1): 74-75.
Dubinsky MC, Mei L, Friedman M, Dhere T, et al. Genome Wide Association (GWA) Predictors of Anti-TNF Alpha Therapeutic Responsiveness in Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Disease. August 2010; 16(8)1357-1366.
Wehbi M, Qayed E, Dhere T, Gondha C, et al. Deep Bile Duct Cannulation Time at Endoscopic Retrograde Cholangiopanceatography: A Forgotten Parameter for Assessment of Endoscopic Competence. Gastroenterology Insights 2010; 2(1): 27-29.
Dhere, T. The use of biologics in inflammatory bowel disease patients with cirrhosis. Inflammatory Bowel Disease Feb 2011; 17(2): E15-16.
Adeyanj O, Okuo D,Huang C, Kumar A, Sauer C, Galloway C, Prasad M, Waters J, Cutler D,Zwick M, Dhere T, Kugathasan S. The common variants of NOD2 risk in African- American with Crohn’s disease is exclusively contributed by recent Caucasian admixture. Inflammatory Bowel Disease December 2012; 18(12): 2357-2359
Bhagavathula A, Middleton J, Gaye B, Alvarez J, Huang C, Sauer C, Tenjarla G, Schoen B, Kumar A, Prasad M, Waters J, Galloway C, Okou D, Ifadeke W, Dhere T, Ziegler T, Tangpricha V, and Kugathasan S. Vitamin D and Bone Minernal Density Status in African-American Children and Crohn’s Disease. J Ped Gastroenterol Nutr Nov 2013; 57(5)587-593.
Mandalia A, Kraft C, and Dhere T. Diverticulitis after FMT for C. difficile infection. Am J Gastro Dec 2014; 109(12) 1956-1957.
Griglione N, Yarandi S, Srinivasan J, Ahearn T, and Dhere T. A comparison of abdominal surgical outcomes between African American and Caucasian Crohn’s patients. Int J Colorectal Dis. Aug 2014; 29(8): 917-922.
Wang X, Kraft C, and Dhere T. The use of standard donors in fecal microbiota transplants. Southern Med J Jan 2015; 108(1): 68-69.
Huang C, Haritunias T, Okou D, Cutler D, Zwick M, Taylor K, Datta L, Manaville J, Alexander J, Baldassano R, Cho J, Cross R, Dassopoulos T, Dhere T, et al. Characterization of genetic loci that affect susceptibility to inflammatory bowel disease in African-Americans. Gastro Aug 2015; 149(6): 1575-1586.
Mandalia A, Hinrichs B, and Dhere T. Meckel’s diverticulum found on virtual capsule endoscopy. Journal of Academic Hospital Medicine October-December 2015.
Mandalia A, Ward A, Tauxe W, Kraft C, and Dhere T. Fecal transplant is as effective and safe in immunocompromised as non-immunocompromised patients for Clostridium difficile. Int J Colorectal Dis. 2015.
Fang S, Kraft CS, Dhere T, Srinivasan J, Begley B, Weinstein D, Shaffer VO. Successful treatment of chronic pouchitis utilizing FMT: a case report. Int J Colorectal Dis. Nov 2015.
Fisher JG, Kalb B, Martin D, Dhere T, Perez SD, Srinivasan JK. Abdominal MRI without Enteral Contrast Accurately Detects Intestinal Fibrostenosis in Patients with Inflammatory Bowel Disease. Am Surg Nov 2015; 81(11): 1118-1124.
McGovern B, Khanna S, Pardi DS, Kelly CR, Craft CS, Dhere T, et al. A novel microbiome therapeutic to increase gut microbiome diversity and prevent recurrent Clostridium difficile infection. Journal of Infectious Diseases Feb 2016.
Tauxe WM, Rebolledo PA, Neish E, Newman KL, Ward A, Dhere T, Kraft CS. Fecal Microbiota Transplant for Clostridium difficile Infection in Older Adults. Therapeutic Advances in Gastro May 2016; 9(3) 273-278.
Pujada A, Walter L, Dhere T, Garg P. Matrix metalloproteinases as potential fecal biomarkers for ulcerative colitis – a function beyond their proteolytic activity. Metalloproteinases in Medicine May 2016; 3: 19-29
Dhere T, Copland I, Garcia M, Chiang KY, Chinnadurai R, Prasad M, Galipeau J, and Kugathasan S. Safety of autologous and metabolically fit bone marrow mesenchymal stromal cells in medically refractory Crohn’s Disease – A dose escalating Phase 1 trial. Aliment Pharmacol Ther Sep 2016; 44(5): 471-481
Brant SR, Okou DT, Simpson CL, Cutler DJ, Haritunians T, Bradfield JP, Chopra P, Prince J, Begum F, Kumar A, Huang C, Venkateswaran S, Datta LW, Wei Z, Thomas K, Herrinton LJ, Klapproth JA, Quiros AJ, Seminerio J, Liu Z, Alexander JS, Baldassano RN, Dudley-Brown S, Cross RK, Dassopoulos T, Denson LA, Dhere TA, et al. Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. Gastro 2016; 152(1): 206-217.
Saeedi B, Morison DG, Craft SK, and Dhere T. Fecal Microbiota Transplant for Clostridium difficile in a pregnant patient. Obstetrics and Gynecology March 2017; 129 (3): 507-509.
Woodworth M, Neish E, Miller N, Dhere T, Burd E, Sitchenk K, and Kraft C. Laboratory Testing of Donors and Stool for Fecal Microbiota Transplantation for Recurrent C. difficile Infection. Journal of Clinical Microbiology. April 2017; 55(4): 1002-1010.
Baxter KJ, Durham M, Ziegler TR, Dhere T, Ricketts R, Srinivasan J. Pediatric short bowel syndrome and subsequent development of inflammatory bowel disease: An illustrative case and literature review. Pediatric Surgery International June 2017; 33(6): 731-736.
Bertha M, Vasantharoopan A, Kumar AI, Bruce B, Prince J, Hofmekler T, Okou D, Chopra P, Wang G, Sauer C, Landers CJ, Hussain SZ, Cross RK, Baldassano RN, Kappelman MD, Katx J, Alexander JS, Kirschner BS, Moulton DE, Asuntokum BO, Patel A, Saeed S, Klapproth JA, Dhere T, Dubinsky M, McGovern D, Kugathasan S. IBD Serology and Disease Outcomes in African-Americans with Crohn’s Disease. IBD December2017; 24(1) 209-16
Woodworth MH, Kraft CS, Meredit EJ, Mehta AK, Wang T, Mamo YT, Dhere T, Sitchenko KL, Patzer RE, Friedman-Moraco RJ. Tacrolimus concentration to dose ratio in solid organ transplant patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. Transpl Infect Dis April 2018; 20(2):12857.
Wang T, Kraft CS, Woodworth MH, Dhere T, and Eaton ME. Fecal Microbiota Transplant for Refractory Clostridium difficile Infection Interrupts 25-Year History of Recurrent Urinary Tract Infections. Open Forum Infect Dis Jan 2018; 5(2):16.
Cheng YW, Phelps E, Ganapini V, Khan N, Ouyang F, Xu H, Khanna S, Tariq R, Friedman- Moraco RJ, Woodworth MH, Dhere T, Kraft CS, Kao D, Smith J, Le L, El-Nachef N, Kaur N, Kowsika S, Ehrlich A, Smith M, Safdar N, Ann Misch E, Allegretti JR, Flynn A, Kassam Z, Sharfuddin A, Vuppalanchi R, Fischer M. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience. Am J Transplant. Feb 2019; 19(2): 501-511.
Muftah M, Mulki R, Dhere T, Keilin S, and Chawla S. Diagnostic and therapeutic considerations for obscure GI bleeding in patients with chronic kidney disease. Annals Gastroenterol 2019; 32 (2) 113-23.
Mo A, Krishnakumar C, Arafat D, Dhere T, Iskandar H, Dodd A, Prince J, and Kugathasan S. Gibson G. African Ancestry Proportion Influences Ileal Gene Expression in Inflammatory Bowel Disease. Cell Mol Gastroenterol Hepatol. Feb 2020.
Sunjara DB, Taborda C, Obeng R, and Dhere T. First case of refractory colitis caused by ocrelizumab. IBD Mar 2020
Dhere T, Dwadasi S, Levy S, Wu R, Kazzi Z, and Iskandar H. Comparison of emergency room use between African-American and Caucasian inflammatory bowel disease (IBD) patients. Journal of Gastroenterology and Hepatology Research 2020.
Steed DB, Wang T, Raheja D, Waldman AD, Babiker A, Dhere T, Kraft CS, Woodworth MH. Gram-Negative Taxa and Antimicrobial Susceptibility after Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.. mSphere. Oct 2020 14;5(5):e00853-20
K. Somineni, Sini Nagpal, Suresh Venkateswaran, David J. Cutler, David T. Okou, Talin Haritunians, Claire L. Simpson, Ferdouse Begum, Lisa W. Datta, Antonio J. Quiros, Jenifer Seminerio, Emebet Mengesha, Jonathan S. Alexander, Robert N. Baldassano, Sharon Dudley-Brown, Raymond K. Cross, Themistocles Dassopoulos, Lee A. Denson, Tanvi A. Dhere, Heba Iskandar, Gerald W. Dryden, Jason K. Hou, Sunny Z. Hussain, Jeffrey S. Hyams, Kim L. Isaacs, Howard Kader, Michael D. Kappelman, Jeffry Katz, Richard Kellermayer, John F. Kuemmerle, Mark Lazarev, Ellen Li, Peter Mannon, Dedrick E. Moulton, Rodney D. Newberry, Ashish S. Patel, Joel Pekow, Shehzad A. Saeed, John F. Valentine, Ming-Hsi Wang, Jacob L. McCauley, Maria T. Abreu, Traci Jester, Zarela Molle-Rios, Sirish Palle, Ellen J. Scherl, John Kwon, John D. Rioux, Richard H. Duerr, Mark S. Silverberg, Michael E. Zwick, Christine Stevens, Mark J. Daly, Judy H. Cho, Greg Gibson, Dermot P.B. McGovern, Steven R. Brant, Subra Kugathasan. Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease. The American Journal of Human Genetics, Mar 2021; 108 (3) 431-45
Cheng YW*, Alhaffar D, Saha S, Khanna S, Bohm M, Phelps E, Ghabril M, Orman E, Sashidhar S, Rogers N, Xu H, Khoruts A, Vaughn B, Kao D, Wong K, Cammarota G, Ianiro G, Dhere T, Kraft CS, Mehta N, Woodworth MH, Allegretti JR, Nativ L, Marcus J, El-Nachef N, Fischer M. Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis. Clin Gastro Hepatol 2021; 19 (8): 1627-34.
ager D*, Kilakkathi SP*, Woodworth MH, Kraft CS, and Dhere T. Earlier use of fecal transplant administration during hospitalization for Clostridioides difficile infection (CDI) may improve outcome. European Journal of Gastroenterology and Hepatology 2021
Hijab E* and Dhere T. Autoimmune enteropathy presenting as ascites in a cirrhotic patient. IBD Nov 2021; 27(12)e145-e146.
Mehta N*, Want T, Friedman-Moraco R, Carpentieri C, Mehta A, Rouphael N, Dhere T, Larsen C, Kraft CK, and Woodworth M. Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients. Journal of Clinical Microbiology 2022 Feb 16;60(2)
Chandrasekhran B*, Boyer D, Owen JA, Wolfarth AA, Saeedi BJ, Dhere T, Iskandar H, Neish AS. Intracolonic Neuropeptide Y Y1 Receptor Inhibition Attenuates Intestinal Inflammation in Murine Colitis and Cytokine Release in IBD Biopsies. IBD 2022 Mar 30;28(4):502-513.
Ali N, Dhere T, Bates J, Lin J. A Guide to Enriching Undergraduate Medical Education with Radiation Oncology. Prac Rad Onc 2022. Submitted.
